October 05, 2018
A subsidiary of B. Braun Melsungen AG has settled Mallinckrodt IP's multiple patent infringement lawsuits in Delaware federal court seeking to block the German pharmaceutical giant from making generic versions of its IV Tylenol, after B. Braun unsuccessfully argued that the suits were filed in the wrong venue under the U.S. Supreme Court's TC Heartland ruling.
December 15, 2017
A Delaware federal judge on Thursday refused a drug and medical device maker's request to dismiss or transfer an infringement suit brought against it over three intravenous painkiller patents, greenlighting discovery to determine if the venue is indeed proper.